AUROBINDO PHARMA LTD vs MANIPAL HEALTH ENTERPRI L
A side-by-side comparison of AUROBINDO PHARMA LTD (AUROPHARMA) and MANIPAL HEALTH ENTERPRI L (MANIPALHOS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, AUROBINDO PHARMA LTD leads AUROPHARMA vs MANIPALHOS on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability22
- Growth02
- Size & financial health40
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
AUROPHARMA takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
MANIPALHOS takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
AUROPHARMA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + []
- − ["The company has delivered a poor sales growth of 6.3% over past five years.", "The company has delivered a poor profit growth of -8.1% over past five years."]
- + ["Company has delivered good sales growth of 20.6% CAGR over last 5 years"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.